DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 32 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $823,000 | +170.7% | 56,764 | +85.1% | 0.67% | +146.5% |
| Q2 2016 | $304,000 | -5.0% | 30,663 | -8.8% | 0.27% | +0.7% |
| Q1 2016 | $320,000 | -17.9% | 33,634 | -3.4% | 0.27% | -4.2% |
| Q4 2015 | $390,000 | -26.7% | 34,819 | -8.4% | 0.28% | -25.3% |
| Q3 2015 | $532,000 | – | 38,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lone Star Value Management LLC | 171,661 | $2,489,000 | 4.72% |
| 1492 Capital Management LLC | 56,764 | $823,000 | 0.67% |
| GREAT POINT PARTNERS LLC | 178,930 | $2,594,000 | 0.66% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,223 | $13,720,000 | 0.63% |
| Timpani Capital Management LLC | 81,815 | $1,186,000 | 0.47% |
| 683 Capital Management, LLC | 187,075 | $2,713,000 | 0.29% |
| Lombard Odier Asset Management (USA) Corp | 150,000 | $2,175,000 | 0.20% |
| Tourbillon Capital Partners, L.P. | 237,874 | $3,449,000 | 0.07% |
| TFS CAPITAL LLC | 10,768 | $156,000 | 0.04% |
| ARDSLEY ADVISORY PARTNERS LP | 12,295 | $178,000 | 0.03% |